[go: up one dir, main page]

ES2197781B1 - Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. - Google Patents

Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Info

Publication number
ES2197781B1
ES2197781B1 ES200102705A ES200102705A ES2197781B1 ES 2197781 B1 ES2197781 B1 ES 2197781B1 ES 200102705 A ES200102705 A ES 200102705A ES 200102705 A ES200102705 A ES 200102705A ES 2197781 B1 ES2197781 B1 ES 2197781B1
Authority
ES
Spain
Prior art keywords
ibuprofen
pharmaceutical compositions
liquid pharmaceutical
based liquid
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES200102705A
Other languages
English (en)
Other versions
ES2197781A1 (es
Inventor
Ana Maria Jimenez Redondo
Laura Berges Abanades
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES200102705A priority Critical patent/ES2197781B1/es
Priority to PCT/ES2002/000572 priority patent/WO2003047550A1/es
Priority to DE60217903T priority patent/DE60217903T2/de
Priority to AT02793140T priority patent/ATE352287T1/de
Priority to EP02793140A priority patent/EP1452169B1/en
Priority to AU2002358819A priority patent/AU2002358819A1/en
Publication of ES2197781A1 publication Critical patent/ES2197781A1/es
Application granted granted Critical
Publication of ES2197781B1 publication Critical patent/ES2197781B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones farmacéuticas líquidas de base acuosa en forma de suspensión para la administración por vía oral de ibuprofeno como principio activo que comprende de 0,8% a 6% en peso por volumen de ibuprofeno; de 0,1% a 2% en peso por volumen de cloruro sódico; de 0,01% a 0,5% en peso por volumen de sacarina sódica; de 0,1% a 2% en peso por volumen de uno o más agentes reguladores del pH en una cantidad suficiente como para ajustar el pH entre 3,8 y 4,8; de 0,01% a 0,5% en peso por volumen de un conservante; junto con una cantidad adecuada de otros excipientes farmacéuticamente aceptables de características viscosizantes y enmascarantes del sabor, así como un procedimiento para su preparación.
ES200102705A 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. Expired - Lifetime ES2197781B1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES200102705A ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
PCT/ES2002/000572 WO2003047550A1 (es) 2001-12-04 2002-12-02 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno
DE60217903T DE60217903T2 (de) 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
AT02793140T ATE352287T1 (de) 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
EP02793140A EP1452169B1 (en) 2001-12-04 2002-12-02 Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
AU2002358819A AU2002358819A1 (en) 2001-12-04 2002-12-02 Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102705A ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Publications (2)

Publication Number Publication Date
ES2197781A1 ES2197781A1 (es) 2004-01-01
ES2197781B1 true ES2197781B1 (es) 2005-02-16

Family

ID=8499662

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200102705A Expired - Lifetime ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Country Status (6)

Country Link
EP (1) EP1452169B1 (es)
AT (1) ATE352287T1 (es)
AU (1) AU2002358819A1 (es)
DE (1) DE60217903T2 (es)
ES (1) ES2197781B1 (es)
WO (1) WO2003047550A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
DE202008006492U1 (de) 2007-02-23 2008-08-21 Basf Se Verwendung von wasserdispergierbaren Carotinoid-Nanopartikeln als Geschmacksmodulatoren, Geschmacksmodulatoren, enthaltend wasserdispergierbare Carotinoid-Nanopartikel
DK2139347T3 (da) 2007-02-23 2011-04-18 Brain Biotechnology Res & Information Network Ag Anvendelse af vanddispergerbare carotenoid-nanopartikler som smagsmodulatorer, smagsmodulatorer indeholdende vanddispergerbare carotenoid-nanopartikler og fremgangsmåder til smagsmodulation
CN101616607B (zh) * 2007-02-23 2014-06-04 B.R.A.I.N.生物技术研究与信息网络股份公司 含有至少一种高倍甜味剂(his)的物质组合物的调味方法
ATE494800T1 (de) 2007-02-23 2011-01-15 Brain Biotechnology Res & Information Network Ag Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
ATE555672T1 (de) 2008-03-05 2012-05-15 Brain Biotechnology Res & Information Network Ag Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
DE202008006164U1 (de) 2008-03-05 2008-10-02 Basf Se Verwendung eines Polyoxyethylensorbitanfettsäureesters zur Geschmacksmodulation von stofflichen Zusammensetzungen, die mindestens einen High Intensity Sweetener (HIS) enthalten
SG11202008204QA (en) * 2018-02-28 2020-09-29 Sumitomo Dainippon Pharma Co Ltd Aqueous suspension pharmaceutical preparation
CN117883379A (zh) * 2021-02-12 2024-04-16 浙江贝灵生物医药有限公司 一种口服碱性溶媒组合物及其制备方法与应用
CN115671046B (zh) * 2022-10-10 2024-04-26 澳美制药(苏州)有限公司 布洛芬混悬滴剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231890B1 (en) * 1996-05-02 2001-05-15 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231890B1 (en) * 1996-05-02 2001-05-15 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug

Also Published As

Publication number Publication date
ES2197781A1 (es) 2004-01-01
DE60217903D1 (de) 2007-03-15
EP1452169B1 (en) 2007-01-24
DE60217903T2 (de) 2007-11-22
WO2003047550A1 (es) 2003-06-12
EP1452169A1 (en) 2004-09-01
AU2002358819A1 (en) 2003-06-17
ATE352287T1 (de) 2007-02-15

Similar Documents

Publication Publication Date Title
EP1708686A4 (en) GENERAL LINEAR SHELL FORM OF FENTANYL FOR ORAL USE AND METHOD OF ADMINISTRATION
PA8548701A1 (es) Azaindoles
WO2003105800A3 (de) Filmförmige mucoadhäsive darreichungsformen zur verabreichung von cannabis-wirkstoffen
PA8591701A1 (es) Derivados de pirrolopirimidina
MXPA05008909A (es) Formulacion intranasal de rotigotina.
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
HRP20020404B1 (hr) Otopine koje sadrže epinastin
AR108594A2 (es) Formulaciones farmacéuticas que conservan el sabor con características farmacéuticas mejoradas
MX2010003923A (es) Formulacion farmaceutica de valsartan.
SE0402762D0 (sv) Indazole sulphonamide derivatives
GT200200065A (es) Composicion parenteral reconstituible
ES2197781B1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
TW200509907A (en) Indol-6-yl sulfonamide derivatives, their preparation and their use in medicaments
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
ATE552825T1 (de) Flüssige orale zusammensetzungen
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200505855A (en) Indol-4-yl sulfonamide derivatives, their reparation and their use in medicaments
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
UY27373A1 (es) Formulaciones de interferón beta-humano
MX2007009312A (es) Preparaciones inyectables de diclofenaco y sus sales farmaceuticamente aceptables.
ZA202301927B (en) Phytonadione compositions

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040101

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2197781B1

Country of ref document: ES